Entheon Biomedical Corp. (CSE:ENBI)
Canada · Delayed Price · Currency is CAD 0.0800
+0.0100 (14.29%)
Oct 9, 2025, 1:08 PM EDT
Entheon Biomedical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
1.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | 250.32K | 60.65K | 31.97% |
| Nov 30, 2022 | 189.68K | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | - | - | - |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| dentalcorp Holdings | 1.62B |
| Sienna Senior Living | 929.68M |
| WELL Health Technologies | 1.12B |
| Cronos Group | 177.69M |
| Extendicare | 1.51B |